CAMP4 Therapeutics Ownership | Who Owns CAMP4 Therapeutics?


OverviewForecastRevenueFinancialsChart

CAMP4 Therapeutics Ownership Summary


CAMP4 Therapeutics is owned by 138.94% institutional investors, 17.96% insiders. 5am venture management is the largest institutional shareholder, holding 29.11% of CAMP shares. NT Ext Equity Mkt Idx Fd - NL is the top mutual fund, with 0.08% of its assets in CAMP4 Therapeutics shares.

CAMP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCAMP4 Therapeutics138.94%17.96%-56.90%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
5am venture management5.87M29.11%$17.61M
Vivo capital3.92M19.45%$11.76M
Enavate sciences gp3.79M18.78%$11.36M
Fmr3.02M15.00%$9.07M
Ah capital management2.13M10.54%$6.38M
Adage capital partners gp1.96M9.73%$5.88M
Harbourvest partners1.27M6.31%$3.82M
Silverarc capital management653.59K3.24%$1.96M
Vanguard group313.51K1.56%$940.52K
Alyeska investment group200.00K0.99%$600.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
5am venture management5.87M6.45%$17.61M
Enavate sciences gp3.79M3.47%$11.36M
Harbourvest partners1.27M1.86%$3.82M
Vivo capital3.92M0.95%$11.76M
Ah capital management2.13M0.46%$6.38M
Silverarc capital management653.59K0.26%$1.96M
Adage capital partners gp1.96M0.01%$5.88M
Alyeska investment group200.00K0.00%$600.00K
Bridgeway capital management25.00K0.00%$75.00K
Tower research capital llc (trc)5.65K0.00%$16.95K

Top Buyers

HolderShares% AssetsChange
Vivo capital3.92M0.95%3.92M
5am venture management5.87M6.45%2.94M
Fmr3.02M0.00%2.42M
Adage capital partners gp1.96M0.01%1.96M
Silverarc capital management653.59K0.26%653.59K

Top Sellers

HolderShares% AssetsChange
Franklin resources---635.05K
Blackrock funding, inc. /de11.44K--72.78K
Charles schwab investment management---16.68K
Vanguard group313.51K--15.38K
Qube research---14.87K

New Positions

HolderShares% AssetsChangeValue
Vivo capital3.92M0.95%3.92M$11.76M
Adage capital partners gp1.96M0.01%1.96M$5.88M
Silverarc capital management653.59K0.26%653.59K$1.96M
Two sigma investments, lp97.37K0.00%97.37K$292.11K
Mariner17.30K0.00%17.30K$51.89K

Sold Out

HolderChange
Your advocates ltd., llp-2.00
Eversource wealth advisors-3.00
Sterling capital management-71.00
Nisa investment advisors-101.00
Wells fargo & company/mn-119.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025273.85%28,010,083139.07%1383.85%13-8-11.11%
Jun 30, 202528-26.32%11,744,55220.46%608.68%14-22.22%10-9.09%
Mar 31, 2025398.33%12,677,518-1.37%342.84%18-50.00%11-
Dec 31, 202436-12,854,103-34-36---
Jun 30, 20241-2-------100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
NT Ext Equity Mkt Idx Fd - NL1.41K0.08%1.00
Fidelity Nasdaq Composite Index794.000.05%-
SSgA U.S. Extended Market Index Class I14.03K0.04%-
Vanguard Instl Ttl Stck Mkt Idx Tr499.000.03%-404.00
NT Quality Small Cap Core178.000.01%-
NT Quality SCC US Fund - L178.000.01%-
NT US Market Cap Idx Fd - L3.53K0.01%-
Blackstone Alternative Multi-Strategy I92.000.01%-99.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 553.000.00%8.00
Guggenheim Active Allocation Fund9.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 20255AM Partners VI, LLC-Buy$4.50M
Sep 11, 2025Polaris Management Co. VII, L.L.C.-Buy$130.77K
Sep 11, 2025Polaris Management Co. VII, L.L.C.-Buy$1.87M
Sep 11, 2025Nashat Amir Buy$130.77K
Sep 11, 2025Nashat Amir Buy$1.87M

Insider Transactions Trends


DateBuySell
2025 Q38-
2025 Q2--
2024 Q2-1
2024 Q1--
2023 Q4--

CAMP Ownership FAQ


Who Owns CAMP4 Therapeutics?

CAMP4 Therapeutics shareholders are primarily institutional investors at 138.94%, followed by 17.96% insiders and -56.90% retail investors. The average institutional ownership in CAMP4 Therapeutics's industry, Biotech Stocks , is 45.24%, which CAMP4 Therapeutics exceeds.

Who owns the most shares of CAMP4 Therapeutics?

CAMP4 Therapeutics’s largest shareholders are 5am venture management (5.87M shares, 29.11%), Vivo capital (3.92M shares, 19.45%), and Enavate sciences gp (3.79M shares, 18.78%). Together, they hold 67.34% of CAMP4 Therapeutics’s total shares outstanding.

Does Blackrock own CAMP4 Therapeutics?

BlackRock is not among the top 10 institutional shareholders of CAMP4 Therapeutics.

Who is CAMP4 Therapeutics’s biggest shareholder by percentage of total assets invested?

5am venture management is CAMP4 Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.45% of its assets in 5.87M CAMP4 Therapeutics shares, valued at 17.61M$.

Who is the top mutual fund holder of CAMP4 Therapeutics shares?

NT Ext Equity Mkt Idx Fd - NL is the top mutual fund holder of CAMP4 Therapeutics shares, with 0.08% of its total shares outstanding invested in 1.41K CAMP4 Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools